Literature DB >> 6094452

Treatment of severe staphylococcal infections with cefotaxime and fosfomycin in combination.

H Portier, J C Tremeaux, P Chavanet, J B Gouyon, J M Duez, A Kazmierczak.   

Abstract

In a prospective study, 23 severe staphylococcal infections (9 meningitis, 10 bone and joint infections, 3 septicaemia, 1 superinfection of a congenital varicella) were treated with cefotaxime and fosfomycin in combination. There was a synergistic effect of the combination for 14 of the 17 strains tested. Three hours after the end of the infusion, mean CSF concentrations of cefotaxime and fosfomycin were respectively at day 2 3.2 mg/l and 31.4 mg/l, at day 4 2.9 mg/l and 33.9 mg/l. All the patients with meningitis or acute bone and joint infections recovered satisfactorily without relapses. Two superinfections were observed (one systemic candidosis and one septicaemia due to Pseudomonas aeruginosa). Clinical tolerance was good and treatment was discontinued for side effects in only three patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094452     DOI: 10.1093/jac/14.suppl_b.277

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.

Authors:  Ashley D Hall Snyder; Brian J Werth; Poochit Nonejuie; John P McRoberts; Joe Pogliano; George Sakoulas; Juwon Yim; Nivedita Singh; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Intracellular bactericidal activity of fosfomycin against staphylococci: a comparison with other antibiotics.

Authors:  M Trautmann; C Meincke; K Vogt; M Ruhnke; A M Lajous-Petter
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

3.  Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.

Authors:  P Chavanet; E Muggeo; A Waldner; S Dijoux; D Caillot; H Portier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

4.  In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; N Peyrard; A Pechinot; M Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

5.  In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; H Beloeil; A Pechinot; F Duigou; J C Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

6.  Current clinical use of intravenous fosfomycin in ICU patients in two European countries.

Authors:  C Putensen; B Ellger; S G Sakka; A Weyland; K Schmidt; M Zoller; N Weiler; D Kindgen-Milles; U Jaschinski; J Weile; S Lindau; M Kieninger; A Faltlhauser; N Jung; P Teschendorf; M Adamzik; M Gründling; T Wahlers; H Gerlach; F-A Litty
Journal:  Infection       Date:  2019-06-12       Impact factor: 3.553

7.  Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.

Authors:  Wolfgang Poeppl; Tilman Lingscheid; Dominik Bernitzky; Uwe Y Schwarze; Oliver Donath; Thomas Perkmann; Nicolas Kozakowski; Roberto Plasenzotti; Gottfried Reznicek; Heinz Burgmann
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

8.  Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections.

Authors:  H Portier; A Kazmierczak; F Lucht; J C Tremeaux; P Chavanet; J M Duez
Journal:  Infection       Date:  1985       Impact factor: 3.553

9.  Bactericidal activity of cefotaxime and fosfomycin in cerebrospinal fluid during the treatment of rabbit meningitis experimentally induced by methicillin-resistant Staphylococcus aureus.

Authors:  A Kazmierczak; A Pechinot; J C Tremeaux; J M Duez; E Kohli; H Portier
Journal:  Infection       Date:  1985       Impact factor: 3.553

10.  Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.

Authors:  R Haag
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.